Brussels Airport has more than doubled its Airside Pharma Transporter (APT) capacity from four to nine units as pharma traffic continues to boom.
The airport said it further shows its commitment to “staying in the lead as the European pharma HUB” and the new units have been added to meet rising demand from shippers and airlines and the additional investment was “crucial”.
The five new APT’s are of the latest generation and feature some new capabilities, such as variable temperature settings and automated temperature reporting.
The new units also use a more traditional energy efficient cooling, powered by solar power technology to operate autonomously for several days. This allows for an energy neutral temperature controlled transport at Brussels Airport.